My Experiences: Leveraging Digital Technologies to Better Understand Mental Health
NCT ID: NCT05753605
Last Updated: 2025-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
302 participants
OBSERVATIONAL
2023-06-26
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Digital technologies such as passive and active sensing from smartphones and from wearable devices are shedding light on the capabilities of tracking new objective measures of health that could translate to key symptoms of mental health conditions. 'Multimodal data' approaches are those that attempt to translate a variety of electrical signals from digital devices to relevant health outcomes. The combination of digital devices to detect multimodal measures of mental health symptoms offers a unique opportunity to take a ground up approach in understanding the fluidity of mental health symptoms occurring at the individual level that might lend insight into new phenotypes of mental health illnesses that could have a physiological underpinning.
The Study Investigators aim to characterize the multiplexing and fluid nature of mental health symptoms across individuals experiencing mental health symptoms and conditions using digital tools (i.e., wearables and mobile apps) and additional context information collected from virtual study support calls.
The Investigators hope to know how objective measures from sensor data translate to core symptoms, episodes and flares across mental health disorders, and develop new (or new applications of) machine learning anomaly detection approaches and determine whether anomalies in expected symptom portraits can be reliably detected and enhanced by the addition of objectively measured data.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part I
NCT05360901
You.Mind! | Boosting First-line Mental Health Care for Youngsters Suffering From Chronic Conditions With Mindfulness
NCT04359563
The Effectiveness of the "MINDLiNG" Digital Mental Health Intervention
NCT06166693
The Effectiveness of Engagement-based Personalization of a Digital Mental Health Intervention
NCT05300906
Mental Health Intervention Research in At-Risk Adolescents
NCT05760443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oura Ring Arm
Participant will be provisioned an Oura smartring.
No interventions assigned to this group
BYOD (Bring Your Own Device) Arm
Participant will use their personal wearable.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experiencing mental health symptoms associated with one or more mental health conditions including major depression, bipolar disorder, anxiety disorder or schizophrenia as defined by cut off scores on validated screening instruments OR a self-reported clinician confirmed diagnosis of a major mood disorder, anxiety disorder or psychotic spectrum disorder at baseline.
* Major depression (Patient Health Questionnaire (PHQ-9)): total score 10+
* Bipolar disorder (Mood Disorder Questionnaire (MDQ)): yes to 6+ items on question 1
* Anxiety disorder (Generalized Anxiety Disorder Scale (GADS-7)): Total score 10+
* Psychotic spectrum (Prodromal Questionnaire - Brief version (PQ-B)): a cut-off of 6+ endorsed positive items and 6+ for the distress subscale total score
* Able to speak, write and read English, given the app will be available only in English
* Able to provide informed consent
* Participants must have a personally owned iPhone 5s or newer (iOS 12 or higher) and use their phone for this study. This includes a willingness to download and use the study applications and sync their phone with the necessary study devices.
* Willingness to continuously wear a personally owned wearable device and permit researcher access to pre-identified streams of data (BYOD arm only) Willingness to continuously wear the Oura smartring and permit research access to its data (Oura arm only)
* Willing to extract 50-60 hairs from the back of the head
* Hair at least 6 centimeters long
* Not currently taking glucocorticoid containing medication (e.g., beclomethasone, betamethasone, budesonide, cortisone, dexamethasone, hydrocortisone, methylprednisolone, prednisolone, prednisone, triamcinolone)
Exclusion Criteria
* Currently or attempting to get pregnant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mind Medicine, Inc.
INDUSTRY
Vector Institute for Artificial Intelligence
UNKNOWN
Cambridge Cognition Ltd
INDUSTRY
University of Washington
OTHER
4YouandMe
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Goodday, PhD
Role: PRINCIPAL_INVESTIGATOR
4YouandMe
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
4YouandMe
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4UMYEXP01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.